Riskpilot← Back to searchSign inGet full accessEQUI AS
ASActiveOrg 821076072Bogstivegen 72, 2360 RudshøgdaOther human health activities n.e.c. · NACE 8699Est. 20181 employees
Revenue 2024
NOK 645K
+38% vs 2023
EBITDA margin
-4.3%
+83% vs 2023
Equity ratio
-347.6%
Financial strength
Net profit 2024
NOK -69K
+72% vs 2023
| Revenue | NOK 645K | +38% |
| EBITDA | NOK -28K | +83% |
| Net profit | NOK -69K | +72% |
| Total assets | NOK 179K | -23% |
| Equity | NOK -621K | -13% |
| Employees | 1 | — |
Legal name
EQUI AS
Org number
821076072
Legal form
Aksjeselskap
NACE code
8699 · Other human health activities n.e.c.
Founded
28. juni 2018
Share capital
NOK 100 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder alene.
Company purpose
Salg av hygieniske og kosmetiske varer og tjenester og andre tjenester og produkter som naturlig faller sammen med dette, herunder å delta i andre selskaper med lignende virksomhet, kjøp og salg av aksjer, eller på annen måte gjøre seg interessert i andre foretagender samt kjøp, salg og utleie av fast eiendom.
Address
Bogstivegen 72, 2360 Rudshøgda
Phone
+4746884700
Email
minequi@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 666 | 759 | 794 | 468 | 645 |
| Staff expenses | −201 | −259 | −182 | −228 | −158 |
| EBITDA | 109 | −136 | −65 | −163 | −28 |
| Depreciation & amort. | −9 | −22 | −0 | −42 | −42 |
| EBIT | 100 | −159 | −65 | −205 | −70 |
| Net financials | 0 | −1 | −2 | −0 | 1 |
| Profit before tax | 100 | −159 | −67 | −205 | −69 |
| Tax | −0 | −28 | −15 | 43 | −0 |
| Net profit | 100 | −131 | −52 | −248 | −69 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 262 | 231 | 218 | 231 | 179 |
| Equity | −121 | −252 | −304 | −552 | −621 |
| Long-term debt | 283 | 283 | 283 | 307 | 307 |
| Short-term debt | 100 | 200 | 239 | 476 | 493 |
| Total debt | 383 | 483 | 522 | 783 | 800 |
EBITDA margin
-4.3%
This company
15.8%
Market median
-127% vs market
20202024
Equity ratio
-347.6%
This company
38.2%
Market median
-1010% vs market
20202024
Return on equity
-6902900.0%
This company
18.4%
Market median
-37515861% vs market
20202024
Net profit margin
-10.7%
This company
8.1%
Market median
-232% vs market
20202024
Asset turnover
3.61×
This company
1.12×
Market median
+222% vs market
20202024
Debt / equity
1.29×
This company
0.62×
Market median
-108% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
SK Chief Executive Officer | Chief Executive Officer | 2018 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2018 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 20% | 20% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of EQUI AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sofia Kortsinskaja | Chief Executive Officer | 0 companies |
| Vadim Frolov | Chairman | 0 companies |